Cargando…
Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations
Proinflammatory cytokines are potent mediators of numerous biological processes and are tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and derive many pathologies, including incidences of autoimmunity and cancer. Therefore, therapies that regulate the activ...
Autores principales: | Rider, Peleg, Carmi, Yaron, Cohen, Idan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204077/ https://www.ncbi.nlm.nih.gov/pubmed/28083070 http://dx.doi.org/10.1155/2016/9259646 |
Ejemplares similares
-
Unique Versus Redundant Functions of IL-1α and IL-1β in the Tumor Microenvironment
por: Voronov, Elena, et al.
Publicado: (2013) -
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors
por: Rasoulouniriana, Diana, et al.
Publicado: (2023) -
Biology of recently discovered cytokines: Interleukin-17 – a unique inflammatory cytokine with roles in bone biology and arthritis
por: Gaffen, Sarah L
Publicado: (2004) -
The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice
por: Litmanovich, Adi, et al.
Publicado: (2018) -
Inflammatory Cytokine: An Attractive Target for Cancer Treatment
por: Lee, Hyang-Mi, et al.
Publicado: (2022)